GBLX — GB Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $3.15m
- $4.64m
Annual cashflow statement for GB Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.7 | -13.1 | -3.73 | -0.531 | -4.13 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 11.7 | 4.37 | 1.76 | -1.47 | 2.45 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.84 | 4 | -0.271 | 0.069 | 0.085 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -9.86 | -4.48 | -2.19 | -1.87 | -1.53 |
| Capital Expenditures | -1.93 | -0.294 | -0.293 | -0.2 | -0.032 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.07 | -0.245 | 4.95 | 1.65 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11 | -0.539 | 4.66 | 1.45 | -0.032 |
| Financing Cash Flow Items | 6.29 | -0.081 | -0.344 | -0.11 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.5 | 4.99 | -1.48 | -0.496 | 1.43 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.35 | -0.03 | 0.994 | -0.912 | -0.124 |